Pretz D, Le Foll C, Rizwan MZ, Lutz TA, Tups A
GLP-1 is a class of weight-loss and diabetes injections semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro)
Its safety profile is well-established, with the most common side effects being mild gastrointestinal issues such as nausea, vomiting, and diarrhea
Turning Cravings Into Clues Rather than resisting cravings blindly, use them as feedback: Ask whats missing
For example, the Food Science & Nutrition study on Eromion lemon extract (which we referenced in the previous section and Lemme references on its website) had less than 100 participants complete the study and lasted for 12 weeks